Patents by Inventor Robert Antony Holt

Robert Antony Holt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7888083
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: April 27, 2010
    Date of Patent: February 15, 2011
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 7732171
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: July 23, 2008
    Date of Patent: June 8, 2010
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 7416865
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: April 27, 2006
    Date of Patent: August 26, 2008
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 7157255
    Abstract: A process is provided for the preparation of a compound of formula (1) wherein R and R? represent optionally substituted hydrocarbyl groups and X represents a hydrocarbyl linking group. The process comprises either the stereoselective reduction of the keto group in a dihydroxy keto precursor followed by selective esterification of a primary hydroxy, or selective esterification of a primary hydroxy of a dihydroxy keto precursor followed by stereoselective reduction of the keto group.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: January 2, 2007
    Assignee: AstraZeneca UK Limited
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Patent number: 6680183
    Abstract: Optically active 2-substituted tetrahydropyran-4-ols or esters thereof may be prepared using esterases or hydrolases from the corresponding racemic mixtures of esters or alcohols. This provides a route to the corresponding optically active ketones. The racemic mixtures are preferably in the cis-form. such mixtures may be produced by reacting but-3-ene-1-ol with an aldehyde in the presence of an acid.
    Type: Grant
    Filed: June 1, 2001
    Date of Patent: January 20, 2004
    Assignee: Zeneca Limited
    Inventors: Robert Antony Holt, Stuart Richard Rigby, David Waterson
  • Publication number: 20030134900
    Abstract: A process is provided for the preparation of a compound of formula (1) 1
    Type: Application
    Filed: November 1, 2002
    Publication date: July 17, 2003
    Inventors: Andrew John Blacker, Christopher David Reeve, Robert Antony Holt
  • Publication number: 20020048797
    Abstract: Optically active 2-substituted tetrahydropyran-4-ols or esters thereof may be prepared using esterases or hydrolases from the corresponding racemic mixtures of esters or alcohols. This provides a route to the corresponding optically active ketones.
    Type: Application
    Filed: June 1, 2001
    Publication date: April 25, 2002
    Applicant: Zeneca Limited
    Inventors: Robert Antony Holt, Stuart Richard Rigby, David Waterson
  • Patent number: 6261830
    Abstract: An enzymatic process for preparing amides of Formula I wherein X, E and * have the meanings defined in the specification. Chiral intermediates useful for preparing compound of Formula I and enzymatic processes for preparing such chiral intermediates are also described.
    Type: Grant
    Filed: May 31, 2000
    Date of Patent: July 17, 2001
    Assignee: Zeneca LTD
    Inventors: John Crosby, John David Pittam, Robert Antony Holt
  • Patent number: 6258574
    Abstract: Optically active 2-substituted tetrahydropyran-4-ols or esters thereof may be prepared using esterases or hydrolases from the corresponding racemic mixtures of esters or alcohols. This provides a route to the corresponding optically active ketones. The racemic mixtures are preferably in the cis-form. such mixtures may be produced by-reacting but-3-ene-1-ol with an aldehyde in the presence of an acid.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: July 10, 2001
    Assignee: Zeneca Limited
    Inventors: Robert Antony Holt, Stuart Richard Rigby, David Waterson
  • Patent number: 6110729
    Abstract: A stereoselective method for making compounds of Formula VIII ##STR1## wherein A and * are as defined in the specification. Enzymic processes and intermediates useful for preparing compound of Formula VIII are disclosed.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: August 29, 2000
    Assignee: Zeneca Limited
    Inventors: John Crosby, John David Pittam, Robert Antony Holt
  • Patent number: 5962282
    Abstract: Optically active 2-substituted tetrahydropyran-4-ols or esters thereof may be prepared using esterases or hydrolases from the corresponding racemic mixtures of esters or alcohols. This provides a route to the corresponding optically active ketones.The racemic mixtures are preferably in the cis-form. such mixtures may be produced by reacting but-3-ene-1-ol with an aldehyde in the presence of an acid.
    Type: Grant
    Filed: May 26, 1998
    Date of Patent: October 5, 1999
    Inventors: Robert Antony Holt, Stuart Richard Rigby, David Waterson
  • Patent number: 5912355
    Abstract: Method of preparing an optically active compound of formula, wherein R and R.sup.1 are independently alkyl, alkenyl, alkynyl, alkoxy, alkoxyalkyl, cycloalkyl, aryl, aralkyl, a heterocyclic group or a C.sub.1 -C.sub.4 alkyl-heterocycle, each being optionally substituted, procided that R and R.sup.1 are not identical and * is an optically active chiral center, from the corresponding racemic ester or diol by treating with a hydrolase enzyme.
    Type: Grant
    Filed: November 12, 1997
    Date of Patent: June 15, 1999
    Assignees: Zeneca Limited, Mochida Pharmaceutical Co., Ltd.
    Inventors: Andrew John Blacker, Andrew George Brewster, Robert Jeffrey Copeland, Robert Antony Holt
  • Patent number: 5854062
    Abstract: Method of preparing an optically active compound of formula, wherein R and R.sup.1 are independently alkyl, alkenyl, alkynyl, alkoxy, alkoxyalkyl, cycloalkyl, aryl, aralkyl, a heterocyclic group or a C.sub.1 -C.sub.4 alkyl-heterocycle, each being optionally substituted, procided that R and R.sup.1 are not identical and * is an optically active chiral center, from the corresponding racemic ester or diol by treating with a hydrolase enzyme. In particular, racemic 2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-1,2 diol, an intermediate in fluconazole synthesis, is resolved using porcine pancreatic lipase or lipase from Chromobacterium viscosum.
    Type: Grant
    Filed: December 11, 1995
    Date of Patent: December 29, 1998
    Assignees: Zeneca Limited, Mochida Pharmaceuticals Co., Ltd.
    Inventors: Andrew John Blacker, Andrew George Brewster, Robert Jeffrey Copeland, Robert Antony Holt